Tag: sclerosis
Sanofi: positive results against multiple sclerosis – 04/17/2024 at 09:54
(AOF) – Sanofi announces that frexalimab, its experimental antibody against multiple sclerosis (MS), achieved a sustained reduction in disease activity and displayed favorable tolerability after one year of treatment in…
Emma Caulfield Ford: This is how the “Buffy” actress lives with multiple sclerosis
Emma Caulfield Ford This is how the “Buffy” actress lives with multiple sclerosis Emma Caulfield Ford is back. © imago images/Starface “Buffy” star Emma Caulfield Ford talks about her life…
Sanofi: Positive results in multiple sclerosis
Read also (CercleFinance.com) – Sanofi announces that the New England Journal of Medicine has published the positive results of a phase II trial showing that frexalimab significantly slowed disease activity…
Multiple sclerosis: no, no diet can cure the disease: Femme Actuelle Le MAG
In France, 120,000 people are affected by multiple sclerosis, indicates the Ministry of Labor, Health and Solidarity. This autoimmune disease which affects the central nervous system is characterized by motor…
Multiple Sclerosis – This is how MS came about: from ancient skeletons to today’s disease – knowledge
Contents Good gene – bad gene: The genes that cause multiple sclerosis today were useful 5,000 years ago. This is shown by new genetic analyzes of prehistoric skeletons. About 5,000…
These 5 warning signs of multiple sclerosis, according to French researchers
Researchers have determined the 5 warning signs that allow a diagnosis of multiple sclerosis to be established. They estimate that several biological mechanisms can appear up to 5 years before…
Merck falls after clinical failure of its multiple sclerosis treatment
Published on 06/12/2023 at 10:32 a.m. December 6 (Reuters) – Merck fell on the stock market on Wednesday morning after the announcement of…
Merck falls after clinical failure of its multiple sclerosis treatment
Published on 06/12/2023 at 1:18 p.m. Photo credit © Reuters (Reuters) – Merck fell on the stock…
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 12/05/2023 at 11:03 p.m.
(Rewrites on all levels) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental multiple sclerosis drug evobrutinib failed to meet the primary goal in highly anticipated late-stage trials, dealing…
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 06/12/2023 at 00:00
(Adds details on pharmaceutical unit results in paragraph 12, as well as information on group performance in last two paragraphs) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental…
Roche: Promising data in multiple sclerosis
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Bristol Myers: New data for multiple sclerosis
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…